BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21059892)

  • 1. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice.
    Wang J; Zhao W; Cheng L; Guo M; Li D; Li X; Tan Y; Ma S; Li S; Yang Y; Chen L; Wang S
    J Immunol; 2010 Dec; 185(12):7654-62. PubMed ID: 21059892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Cho HJ; Cheong JY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
    Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
    Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
    Xiong SQ; Lin BL; Gao X; Tang H; Wu CY
    Int Immunopharmacol; 2007 May; 7(5):578-87. PubMed ID: 17386405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice.
    Zong L; Peng H; Sun C; Li F; Zheng M; Chen Y; Wei H; Sun R; Tian Z
    Nat Commun; 2019 Jan; 10(1):221. PubMed ID: 30644386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.
    Sitia G; Aiolfi R; Di Lucia P; Mainetti M; Fiocchi A; Mingozzi F; Esposito A; Ruggeri ZM; Chisari FV; Iannacone M; Guidotti LG
    Proc Natl Acad Sci U S A; 2012 Aug; 109(32):E2165-72. PubMed ID: 22753481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D Virus-Specific CD8
    Kefalakes H; Koh C; Sidney J; Amanakis G; Sette A; Heller T; Rehermann B
    Gastroenterology; 2019 May; 156(6):1805-1819.e9. PubMed ID: 30664876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pro-inflammatory CD205
    Yong L; Li M; Gao Y; Deng Y; Liu W; Huang D; Ren C; Liu M; Shen J; Hou X
    Sci Rep; 2017 Apr; 7():46765. PubMed ID: 28436459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ.
    Dubrot J; Milheiro F; Alfaro C; Palazón A; Martinez-Forero I; Perez-Gracia JL; Morales-Kastresana A; Romero-Trevejo JL; Ochoa MC; Hervás-Stubbs S; Prieto J; Jure-Kunkel M; Chen L; Melero I
    Cancer Immunol Immunother; 2010 Aug; 59(8):1223-33. PubMed ID: 20336294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of hepatitis B virus infection.
    Chisari FV; Isogawa M; Wieland SF
    Pathol Biol (Paris); 2010 Aug; 58(4):258-66. PubMed ID: 20116937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
    Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12.
    Quetglas JI; Dubrot J; Bezunartea J; Sanmamed MF; Hervas-Stubbs S; Smerdou C; Melero I
    Mol Ther; 2012 Sep; 20(9):1664-75. PubMed ID: 22735380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
    Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
    Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer.
    Guo Z; Cheng D; Xia Z; Luan M; Wu L; Wang G; Zhang S
    J Transl Med; 2013 Sep; 11():215. PubMed ID: 24044888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lymphotoxin-driven pathway to hepatocellular carcinoma.
    Haybaeck J; Zeller N; Wolf MJ; Weber A; Wagner U; Kurrer MO; Bremer J; Iezzi G; Graf R; Clavien PA; Thimme R; Blum H; Nedospasov SA; Zatloukal K; Ramzan M; Ciesek S; Pietschmann T; Marche PN; Karin M; Kopf M; Browning JL; Aguzzi A; Heikenwalder M
    Cancer Cell; 2009 Oct; 16(4):295-308. PubMed ID: 19800575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL13-mediated recruitment of intrahepatic CXCR5
    Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
    J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
    Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
    Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.